Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primer: the fallacy of subgroup analysis.

Francis Guillemin1

  • 1School of Public Health, Nancy University, and Clinical Epidemiology Centre Inserm CIE6, Nancy-University Hospital, France. francis.guillemin@medecine.uhp-nancy.fr

Nature Clinical Practice. Rheumatology
|June 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in prevalence and disability burden of main rheumatic and musculoskeletal diseases in France 2008-2022.

RMD open·2026
Same author

Development and validation of clinical criteria for the definition of disease activity in adult-onset Still's disease: a cohort study.

The Lancet. Rheumatology·2026
Same author

Safety and efficacy of direct versus conventional transfer to angiography suite in patients with severe acute stroke treated with thrombectomy (DIRECT ANGIO) in France: a multicentre, open-label, blinded-endpoint, randomised controlled trial.

The Lancet. Neurology·2026
Same author

Sante publique (Vandoeuvre-les-Nancy, France)·2026
Same author

Effect of Endovascular Treatment in HERMES Patients With Isolated Occlusion of the Intracranial Internal Carotid Artery.

Stroke (Hoboken, N.J.)·2026
Same author

A CT imaging-based prediction model of functional outcome and benefit of endovascular thrombectomy for ischemic stroke.

European radiology·2026
Same journal

New approaches for managing antiphospholipid syndrome.

Nature clinical practice. Rheumatology·2009
Same journal

Imaging the painful osteoarthritic knee joint: what have we learned?

Nature clinical practice. Rheumatology·2009
Same journal

Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside.

Nature clinical practice. Rheumatology·2009
Same journal

Time for new outcome measures in hand osteoarthritis?

Nature clinical practice. Rheumatology·2009
Same journal

Is spleen tyrosine kinase inhibition an effective therapy for patients with RA?

Nature clinical practice. Rheumatology·2009
Same journal

Is tocilizumab in combination with traditional DMARDs safe and effective for patients with active RA?

Nature clinical practice. Rheumatology·2009
See all related articles

Subgroup analyses in clinical trials can guide decisions but require caution. Pre-planned, properly powered studies with formal statistical tests are essential to avoid misinterpretation and ensure reliable patient subgroup insights.

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Rheumatology Research

Background:

  • Randomized clinical trials (RCTs) are designed for group comparisons.
  • Identifying patient subgroups of interest for clinical decisions is desirable but challenging.
  • Subgroup analyses in RCTs can lead to data misinterpretation if not handled carefully.

Purpose of the Study:

  • To review the appropriate conduct and interpretation of subgroup analyses in clinical trials.
  • To highlight potential pitfalls and caveats associated with subgroup analysis.
  • To establish the legitimate role of subgroup analyses in rheumatology clinical trials.

Main Methods:

  • Review of methodological considerations for subgroup analyses.
  • Discussion of statistical requirements, including pre-planning and power.

Related Experiment Videos

  • Examination of potential biases and reporting issues.

    • Main Results:

    • Subgroup analyses require careful execution to avoid misinterpretation.
    • Pre-planned analyses with formal statistical tests of interaction on proper subgroups are crucial.
    • Caveats include false positives/negatives, chance findings, lack of power, and multiple testing issues.

    Conclusions:

    • Subgroup analyses can offer valuable exploratory information for clinical decisions.
    • Adherence to recommendations and guidelines is vital for their legitimate use.
    • Properly conducted subgroup analyses have a place in rheumatology clinical trials.